Blood Pressure and Risk of Clinical Events in Peripheral Artery Disease
Saket Girotra(The University of Texas Southwestern Medical Center), Joshua A. Beckman(Clinical Research Institute), Mohammed Ali Al-Garadi(Vanderbilt University Medical Center), Michael E. Matheny(Department of Veterans Affairs), Dharam J. Kumbhani(Southwestern Medical Center), Mary Vaughan‐Sarrazin(University of Iowa), Richard M. Hoffman(University of Iowa), Kim G. Smolderen(Yale University), Brian C. Lund(University of Iowa), Rohit Nathani(Southwestern Medical Center), James A. de Lemos(Universität Hamburg), Diana Jalal(University of Iowa), Cathy Nguyen(The University of Texas MD Anderson Cancer Center), Shipra Arya(Arya Vaidya Sala), Wanpen Vongpatanasin(Southwestern Medical Center), Paul S. Chan(Saint Luke's Hospital), Glenn T. Gobbel(Valley Health System), Anthony A. Bavry, Qiang Li(Veterans Health Administration), Ajay Gupta
Cited by 0
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation
|Circulation|2000|1.6k
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
|JAMA|2010|1.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975